Myriad Genetics Partners with PATHOMIQ to add Artificial Intelligence Technology Platform to its Oncology Portfolio
SALT LAKE CITY, Feb. 24, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostic testing...
Healthcare
Entera Bio to Participate in Upcoming Events
JERUSALEM, Feb. 24, 2025 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), (“Entera” or the “Company”) a leader in the...
Vivos Therapeutics Expands Strategic Alliance in Colorado and Seeks New Sleep Center Affiliations and Acquisitions Nationwide
Vivos announces immediate expansion of its new alliance model into two additional Colorado locations as initial reports show sleep apnea...
LifeMD® Announces Entry Into the Behavioral Health Market
Expansion to Include Teletherapy, Psychiatry and Medication Management Behavioral Health Offering to be Led by Industry Veteran Julian Cohen NEW...
Vantage Foundation Brings Hope and Support to Patients at National Burn Hospital, Hanoi
HANOI, Vietnam, Feb. 24, 2025 /PRNewswire/ -- Vantage Foundation proudly announces its partnership with National Burn Hospital Le Huu Trac in Hanoi,...
Leading Healthcare Institutions Adopt MSK-ACCESS® for Liquid Biopsy Testing
SOPHiA GENETICS enables institutions across the globe to launch world-class oncology testing BOSTON, MA and ROLLE, Switzerland, Feb. 24, 2025 /PRNewswire/...
Deerfield Management Announces Collaboration with QIA as Part of its Fund of Funds VC Program and the Opening of a Regional Office in Doha
Deerfield Management to collaborate with QIA as part of Fund of Funds venture capital programRegional office set to open in...
Hospital shooting highlights the dangers and violence nurses often face at work
One in four nurses face workplace violence, a rate higher than police and correctional officers. Hospital shooting highlights the dangers...
Press Release: ECCO 2025: new duvakitug data reinforce best-in-class potential in ulcerative colitis and Crohn’s disease
ECCO 2025: new duvakitug data reinforce best-in-class potential in ulcerative colitis and Crohn’s disease New detailed data from the RELIEVE...
Teva and Sanofi Present New Positive Phase 2b Study Results at ECCO 2025 Reinforcing Best-in-Class Potential of Duvakitug (Anti-TL1A) in Ulcerative Colitis and Crohn’s Disease
Teva hosting investor call Monday, February 24 at 8:00 a.m. U.S. ETNew detailed data from the RELIEVE UCCD study support...
ZEISS Shapes the Future of Metrology with Cutting-Edge Technologies Revealed at Event
ZEISS Industrial Quality Solutions will host its first-ever digital launch event for the USA and Canada, introducing seven metrology innovations...
The OhmX RAMP UP Grant Awarded to 15 Laboratories to Advance Genomic Research
PROVIDENCE, R.I., Feb. 21, 2025 /PRNewswire/ -- Nabsys 2.0, LLC (Nabsys) and Hitachi High-Tech America, Inc. (HTA) have revealed the...
Guidehouse Appoints New Healthcare Technology and Managed Services Leaders
Erik Barnett and Brian Smit to power firm's commitment to AI-driven transformation and revenue cycle efficiency MCLEAN, Va., Feb. 21,...
GRAIL to Present at TD Cowen 45th Annual Health Care Conference
MENLO PARK, Calif., Feb. 21, 2025 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect...
Walker Healthforce Successfully Achieves ISO/IEC 27001 Certification
BLOOMFIELD HILLS, Mich., Feb. 21, 2025 /PRNewswire/ -- Walker Healthforce (www.walkerhealthforce.com), a Certified Woman and Minority owned (WMBE) healthcare technology...
Coreline Soft Leads AI Medical Imaging Innovation at STR 2025
Introducing the AVIEW lineup specialized in simultaneous diagnosis and analysis of thoracic diseasesParticipating in HIMSS on March 3rd and completing...
Safe Supply Streaming Co Ltd. Announces Completion of Safety Strips Tech Corp. Acquisition
Toronto, Ontario--(Newsfile Corp. - February 21, 2025) - Safe Supply Streaming Co Ltd. (CSE: SPLY) (FSE: QM4) (OTCQB: SSPLF) ("Safe...
Biostax Corp Announces Voluntary Delisting from OTC Pink Market and SEC Deregistration
ORLANDO, Fla., Feb. 21, 2025 (GLOBE NEWSWIRE) -- Biostax Corp (OTC Pink: BIOX) ("Biostax" or "the Company"), a biopharmaceutical company...
Tempus and Stemline Therapeutics, Inc., A Subsidiary of the Menarini Group, Announce Collaboration to Implement Tempus Next, an AI-Enabled Care Pathway Intelligence Platform to Support Patients with Metastatic Breast Cancer
Up to 50% of patients with ER+/HER2- mBC could develop ESR1 mutations as a result of prior exposure to endocrine...
Neuronetics to Report Fourth Quarter 2024 Financial and Operating Results and Host Conference Call
MALVERN, Pa., Feb. 21, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing,...